Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EIF4E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PLEKHA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTDNEP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSGA10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC19A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00458 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IL10RA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALDH1L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIPA1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSU1P2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEDD4L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927237 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PEAR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01056 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on